0001009448-18-000001.txt : 20180410 0001009448-18-000001.hdr.sgml : 20180410 20180410125025 ACCESSION NUMBER: 0001009448-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180410 DATE AS OF CHANGE: 20180410 EFFECTIVENESS DATE: 20180410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BriaCell Therapeutics Corp. CENTRAL INDEX KEY: 0001610820 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-309749 FILM NUMBER: 18747471 BUSINESS ADDRESS: STREET 1: 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR CITY: WEST VANCOUVER STATE: A1 ZIP: V7T 2X1 BUSINESS PHONE: (604) 921-1810 MAIL ADDRESS: STREET 1: 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR CITY: WEST VANCOUVER STATE: A1 ZIP: V7T 2X1 FORMER COMPANY: FORMER CONFORMED NAME: Ansell Capital Corp. DATE OF NAME CHANGE: 20140613 D 1 primary_doc.xml X0708 D LIVE 0001610820 BriaCell Therapeutics Corp. SUITE 300, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 BRITISH COLUMBIA, CANADA V7T 2X1 (604) 921-1810 BRITISH COLUMBIA, CANADA Ansell Capital Corp. Corporation true Charles Wiseman Suite 300, Bellevue Center 235-15th Street West Vancouver A1 BRITISH COLUMBIA, CANADA V7T 2X1 Director Saeid Babaei Suite 300, Bellevue Center 235-15th Street West Vancouver A1 BRITISH COLUMBIA, CANADA V7T 2X1 Director William V. Williams Suite 300, Bellevue Center 235-15th Street West Vancouver A1 BRITISH COLUMBIA, CANADA V7T 2X1 Executive Officer Director President & Chief Executive Officer Martin Schmieg Suite 300, Bellevue Center 235-15th Street West Vancouver A1 BRITISH COLUMBIA, CANADA V7T 2X1 Director Gadi Levin Suite 300, Bellevue Centre 235-15th Street West Vancouver A1 BRITISH COLUMBIA, CANADA V7T 2X1 Executive Officer Chief Financial Officer and Corporate Secretary Rahoul Sharan Suite 300, Bellevue Center 235-15th Street West Vancouver A1 BRITISH COLUMBIA, CANADA V7T 2X1 Director Biotechnology Decline to Disclose 06b false 2018-03-27 false true true true false 0 Newbridge Securities Corporation (LifeTech Capital division) 104065 None None 5200 Town Center Circle Tower 1, Suite 306 Boca Raton FL FLORIDA 33486 NJ NEW JERSEY NY NEW YORK true 800000 800000 0 false 3 64000 0 The above figure does not include the grant of a warrant fee equal to 8% of all notes converted, payable to Newbridge Securities Corporation upon conversion. 0 false BriaCell Therapeutics Corp. William Williams Dr. William V. Williams President & Chief Executive Officer 2018-04-09